Correlation Between Summit Therapeutics and SHUAA Partners

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and SHUAA Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and SHUAA Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and SHUAA Partners Acquisition, you can compare the effects of market volatilities on Summit Therapeutics and SHUAA Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of SHUAA Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and SHUAA Partners.

Diversification Opportunities for Summit Therapeutics and SHUAA Partners

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Summit and SHUAA is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and SHUAA Partners Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SHUAA Partners Acqui and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with SHUAA Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SHUAA Partners Acqui has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and SHUAA Partners go up and down completely randomly.

Pair Corralation between Summit Therapeutics and SHUAA Partners

If you would invest  450.00  in Summit Therapeutics PLC on November 5, 2024 and sell it today you would earn a total of  1,548  from holding Summit Therapeutics PLC or generate 344.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.41%
ValuesDaily Returns

Summit Therapeutics PLC  vs.  SHUAA Partners Acquisition

 Performance 
       Timeline  
Summit Therapeutics PLC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Summit Therapeutics PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, Summit Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
SHUAA Partners Acqui 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SHUAA Partners Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, SHUAA Partners is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Summit Therapeutics and SHUAA Partners Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Summit Therapeutics and SHUAA Partners

The main advantage of trading using opposite Summit Therapeutics and SHUAA Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, SHUAA Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SHUAA Partners will offset losses from the drop in SHUAA Partners' long position.
The idea behind Summit Therapeutics PLC and SHUAA Partners Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments